Bianca Altvater

2.1k total citations
44 papers, 1.4k citations indexed

About

Bianca Altvater is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Bianca Altvater has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 26 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Bianca Altvater's work include CAR-T cell therapy research (30 papers), Immune Cell Function and Interaction (19 papers) and Immunotherapy and Immune Responses (14 papers). Bianca Altvater is often cited by papers focused on CAR-T cell therapy research (30 papers), Immune Cell Function and Interaction (19 papers) and Immunotherapy and Immune Responses (14 papers). Bianca Altvater collaborates with scholars based in Germany, United States and Poland. Bianca Altvater's co-authors include Claudia Rössig, Sareetha Kailayangiri, Sibylle Pscherer, Heribert Juergens, Silke Landmeier, Silke Jamitzky, Wolfgang Hartmann, Martin Pulé, Jutta Meltzer and Uta Dirksen and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Bianca Altvater

44 papers receiving 1.4k citations

Peers

Bianca Altvater
Reed M. Hawkins United States
Navin K. Chintala United States
Brent Tan United States
Geralyn M. Meny United States
Natalie B. Collins United States
Bianca Altvater
Citations per year, relative to Bianca Altvater Bianca Altvater (= 1×) peers Sareetha Kailayangiri

Countries citing papers authored by Bianca Altvater

Since Specialization
Citations

This map shows the geographic impact of Bianca Altvater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bianca Altvater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bianca Altvater more than expected).

Fields of papers citing papers by Bianca Altvater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bianca Altvater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bianca Altvater. The network helps show where Bianca Altvater may publish in the future.

Co-authorship network of co-authors of Bianca Altvater

This figure shows the co-authorship network connecting the top 25 collaborators of Bianca Altvater. A scholar is included among the top collaborators of Bianca Altvater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bianca Altvater. Bianca Altvater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kailayangiri, Sareetha, et al.. (2024). Protocol for assessing GD2 on formalin-fixed paraffin-embedded tissue sections using immunofluorescence staining. STAR Protocols. 5(3). 103199–103199. 1 indexed citations
2.
Lee, Kwang Seok, Susanne Häfner, Bianca Altvater, et al.. (2024). Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma. Clinical Cancer Research. 30(21). 4974–4986. 1 indexed citations
3.
Jamitzky, Silke, Bianca Altvater, Lisa Richter, et al.. (2024). Ganglioside SSEA-4 in Ewing sarcoma marks a tumor cell population with aggressive features and is a potential cell-surface immune target. Scientific Reports. 14(1). 11935–11935. 1 indexed citations
4.
Altvater, Bianca, Sareetha Kailayangiri, Jutta Meltzer, et al.. (2023). CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process. Cancer Gene Therapy. 30(10). 1355–1368. 13 indexed citations
5.
Trautmann, Marcel, Arne Krüger, Inga Grünewald, et al.. (2019). Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma. Molecular Cancer Therapeutics. 18(4). 834–844. 28 indexed citations
6.
Kailayangiri, Sareetha, Bianca Altvater, Claudia Rössig, et al.. (2019). SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma. Clinical Cancer Research. 25(12). 3718–3731. 38 indexed citations
7.
Rössig, Claudia, Sareetha Kailayangiri, Silke Jamitzky, & Bianca Altvater. (2018). Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers. Frontiers in Oncology. 8. 513–513. 33 indexed citations
8.
Trautmann, Marcel, Konrad Steinestel, Inga Grünewald, et al.. (2017). FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma. Clinical Cancer Research. 23(20). 6227–6238. 38 indexed citations
9.
Inselmann, Sabrina, Tim Sauer, Christoph Schliemann, et al.. (2016). PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation. Bone Marrow Transplantation. 52(2). 317–320. 68 indexed citations
10.
Virts, Elizabeth L., Ralf Einholz, Katheryne Z. Edson, et al.. (2016). Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies. Gene Therapy. 23(7). 615–626. 30 indexed citations
11.
Altvater, Bianca, Jenny Potratz, Jutta Meltzer, et al.. (2014). Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function. Oncology Reports. 32(2). 845–852. 14 indexed citations
12.
Altvater, Bianca, Sareetha Kailayangiri, Martina Ahlmann, et al.. (2014). Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals. Cancer Immunology Immunotherapy. 63(10). 1047–1060. 18 indexed citations
13.
Kailayangiri, Sareetha, Laura Beck, Bianca Altvater, et al.. (2013). Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging. British Journal of Cancer. 109(3). 658–666. 24 indexed citations
14.
Koschmieder, Steffen, Mirle Schemionek, Bianca Altvater, et al.. (2011). NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive mice. Leukemia. 26(3). 465–474. 48 indexed citations
15.
Altvater, Bianca, Sibylle Pscherer, Silke Landmeier, et al.. (2011). Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens. Cancer Immunology Immunotherapy. 61(3). 385–396. 42 indexed citations
16.
Altvater, Bianca, Silke Landmeier, Sibylle Pscherer, et al.. (2009). 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells. Clinical Cancer Research. 15(15). 4857–4866. 165 indexed citations
17.
Brinkrolf, Peter, Silke Landmeier, Bianca Altvater, et al.. (2009). A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease. International Journal of Cancer. 125(4). 879–886. 46 indexed citations
18.
Landmeier, Silke, Bianca Altvater, Sibylle Pscherer, et al.. (2009). Activated Human γδ T Cells as Stimulators of Specific CD8+ T-cell Responses to Subdominant Epstein Barr Virus Epitopes. Journal of Immunotherapy. 32(3). 310–321. 28 indexed citations
19.
Rössig, Claudia, Sibylle Pscherer, Bianca Altvater, et al.. (2005). Target Antigen Expression on a Professional Antigen-Presenting Cell Induces Superior Proliferative Antitumor T-Cell Responses via Chimeric T-Cell Receptors. Journal of Immunotherapy. 29(1). 21–31. 23 indexed citations
20.
Rössig, Claudia, Sibylle Pscherer, Silke Landmeier, et al.. (2005). Adoptive Cellular Immunotherapy with CD19-Specific T Cells. Klinische Pädiatrie. 217(6). 351–356. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026